Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events - PubMed
4 hours ago
- #ezetimibe
- #primary prevention
- #cardiovascular health
- Ezetimibe alone reduces cardiovascular events in individuals aged ≥75 without coronary artery disease history.
- Cholesterol absorption efficiency increases with age, making ezetimibe particularly beneficial for older adults.
- Ezetimibe may be more effective than certain statins in reducing non-HDL cholesterol.
- The drug's benefits include fewer adverse effects and better long-term adherence in primary prevention.
- Future studies are needed to confirm ezetimibe's role in slowing atherosclerosis in older patients.